Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia.

Ge, Yuqiu; Wang, Qiangdong; Shao, Wei; Zhao, You; Shi, Qianqian; Yuan, Qinbo; Cui, Li

Ge, Yuqiu; Wang, Qiangdong; Shao, Wei; Zhao, You; Shi, Qianqian; Yuan, Qinbo; Cui, Li.

Afiliación

Ge Y; Department of Public Health and Preventive Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
Wang Q; Department of Urology, Huaiyin Hospital of Huai'an City, Huai'an, China.
Shao W; Department of Urology, Huaiyin People's Hospital of Huai'an City, Huai'an, China.
Zhao Y; Department of Science and Technology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China.
Shi Q; Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Yuan Q; Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Cui L; Department of Urology, Huaiyin Hospital of Huai'an City, Huai'an, China.

J Cancer ; 11(15): 4542-4549, 2020.

Article en En | MEDLINE | ID: mdl-32489471

Palabras clave

benign prostatic hyperplasia; diagnostic biomarker; microRNA; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google